- Medical Devices
- Friday, 23 Aug 2019
Gastric Balloon Market to double up by 2027 US$ 152.1 Mn
The gastric balloon is a niche market in nature with limited number of players, having considerable revenue in the market. Most of the companies operating in the gastric balloon market are offering their products in the European and the Middle East region, whereas, only three products have FDA approvals for the commercialization of their products.
The most notable market participants are Apollo Endosurgery, Inc. and Allurion Technologies, Inc., ENDALIS, Helioscopie Medical Implants, LEXEL SRL, MEDSIL, Obalon Therapeutics, Inc., ReShape Lifesciences, Inc., Silimed, and Spatz FGIA, Inc. occupying a considerable share of the market owing to their offerings to the market.
Market leaders are involved in activities such as, obtaining approvals to serve a better customer base. For instance, In December, 2018, Obalon received FDA approval of the Obalon Navigation System, which eliminates the need to use x-ray when placing the Obalon Balloon System. The Obalon Navigation System and Touch Inflation Dispenser are expected to be commercially available during the first quarter of 2019 in the United States. Also, during February, 2018, Apollo received approval from the South Korean Ministry of Food and Drug Safety’s (MFDS) for the ORBERA Intragastric Balloon System. Shin Han Systek Co. Ltd. was declared as the exclusive distributor for ORBERA in South Korea. Owing to these approvals, it has been possible for the companies to serve larger customer base as well as provide better weight loss solutions to the patients.
The global gastric balloon market is expected to reach US$ 152.1 Mn in 2027 from US$ 67.3 Mn in 2018. The gastric balloon market is estimated to grow with a CAGR of 9.7% from 2019-2027.
Along with obtaining approvals, various companies have signed agreements in order to strengthen as well as extend its customer base. Additionally various companies are also undergoing other strategic alliances such as collaboration partnerships to garner their significance and remain competitive in the market.
Related Industry Updates
Covid-19 Impact on Radiofrequency Ablation Devices Market Growth and Trends to 2018-2025 With Top Companies Like Avanos Medical, Inc.,Medtronic,Boston Scientific Corporation, AngioDynamics,Hologic Inc.
Oct 16, 2020
Biomaterials Market 2028 Global Forecasts and Key Regions Analysis
Apr 12, 2023
India Bioreactors Market Revenue is expected to Surpass US$ 164.8 Mn by 2027
Apr 07, 2021
Bioresorbable Implants Market - Important Changes in Industry Dynamics
Mar 23, 2021
Medical Device Outsourcing Market Size, Industry Analysis, Growth Factors, Trends, and Regional Forecast to 2027 | Creganna,General Electric Company,Heraeus Holding,Integer Holdings Corporation
May 08, 2021
Cryostat Microtome Equipment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type ( Manual Microtome Cryostat Equipment, Semi-automatic Microtome Cryostat Equipment, Automatic Cryostat Microtome Equipment ); End User ( Hospitals, Ambulatory Surgical Centers, Research Centers )
Apr 16, 2021
Europe Colorectal Cancer Market is Expected to Grow at a CAGR of 3.5% in 2020-2027 with Top key players Epigenomics AG, Novigenix SA, Volitionrx Limited, Abbott Laboratories, Amgen Inc.
Dec 08, 2020